603301.SS SHH
Zhende Medical Co., Ltd.
1W: -6.0%
1M: -8.0%
3M: -10.6%
YTD: -15.3%
1Y: +238.3%
3Y: +187.6%
5Y: +99.1%
¥75.17 ($11.20)
-0.63 (-0.83%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$461M
+2.0% ▲
5Y CAGR: +18.5%
Capital Expenditures
$770M
-28.4% ▼
5Y CAGR: +23.0%
Free Cash Flow
-$309M
-109.7% ▼
Dividends Paid
$159M
+62.4% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$455M
+55.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $3.0B | $721M | $703M | $198M | $397M |
| Depreciation & Amort. | $79M | $142M | $194M | $243M | $247M |
| Stock-Based Comp. | $0 | $15M | $20M | $0 | $0 |
| Change in Working Capital | -$151M | -$114M | $145M | -$270M | -$152M |
| Other Non-Cash Items | $221M | $71M | $204M | $281M | -$31M |
| Operating Cash Flow | $3.1B | $818M | $1.2B | $452M | $461M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.1B | -$695M | -$754M | -$599M | -$770M |
| Acquisitions (Net) | -$92M | -$546M | -$26M | -$312M | -$49M |
| Investment Purchases | -$1.3B | -$576M | -$303M | -$570M | -$1.4B |
| Investment Sales | $872M | $1.0B | $86M | $411M | $1.3B |
| Other Investing | -$163M | $241M | $3M | $13M | $125M |
| Investing Cash Flow | -$1.8B | -$554M | -$993M | -$1.1B | -$768M |
| — Financing Activities — | |||||
| Net Debt Issuance | $7M | $352M | -$136M | $110K | $24M |
| Stock Repurchased | $0 | -$133M | -$113M | $0 | $0 |
| Dividends Paid | -$60M | -$523M | -$136M | -$424M | -$159M |
| Other Financing | -$206M | -$76M | $756M | $323K | -$34M |
| Financing Cash Flow | -$278M | -$380M | $456M | -$423M | -$169M |
| Net Change in Cash | $956M | -$155M | $706M | -$1.0B | -$455M |
| Cash End of Period | $1.5B | $1.4B | $2.1B | $1.0B | $589M |
| Free Cash Flow | $2.0B | $122M | $492M | -$147M | -$309M |